The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRuffer Regulatory News (RICA)

Share Price Information for Ruffer (RICA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 271.00
Bid: 270.50
Ask: 272.00
Change: -0.50 (-0.18%)
Spread: 1.50 (0.555%)
Open: 269.00
High: 272.50
Low: 269.00
Prev. Close: 271.50
RICA Live PriceLast checked at -
Ruffer Investment Company is an Investment Trust

To achieve capital and income return of twice the Bank of England base rate by investing through internationally listed securities and bonds.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Monthly Investment Report May 2020

9 Jun 2020 18:15

RNS Number : 4488P
Ruffer Investment Company Limited
09 June 2020
 

RUFFER INVESTMENT COMPANY LIMITED

(a closed-ended investment company incorporated in Guernsey with registration number 41996)

LEI 21380068AHZKY7MKNO47

 

 

Attached is a link to the Monthly Investment Report for May 2020.

 

http://www.rns-pdf.londonstockexchange.com/rns/4488P_1-2020-6-9.pdf

 

 

During May, the net asset value of the Company rose by 1.3%. This compares with a rise of 3.4% in the FTSE All-Share index.

 

The last month has seen stock markets continue to try and put the events of March down as a bad dream with equities again moving higher. The slowdown in the level of cases in the developed world combined with some easing of lockdown restrictions has given hope that the global economy will recover and in reasonably short order. The anaesthetic of central banks stimulus has once again been sufficient to postpone all ills. As was the case in April, gold mining equities were the largest contributor to returns. The gold price only rose by 2.6% during the month, but mining equities rose in some cases by more than 10%.

 

Looking at the surface one would assume that not much has changed, but within equity markets there were some signs of a shift in tone. The NASDAQ, with its tilt towards technology companies, remained one of the better performing equity markets globally. It was the announcement of the proposed EU recovery fund, however, which saw some of the more 'unloved' areas of equity markets recover sharply. The Company holds its own expressions of the technology world via the likes of Ocado (+71% for the year to date) and eHealth (+36%), as well as an allocation to US healthcare, a relative outperformer. The majority of our equity exposure, however, remains in the more unfashionable areas of equity markets. These companies tend to be more geared into the real economy and this has been an uncomfortable place to be, but the tail end of the month hinted at a possible shift in market favour.

 

The late month rotation into more cyclical equities was apparently catalysed by the announcement of the EU recovery plan. Whilst there will inevitably be further infighting within the eurozone, and objections from those that trumpet austerity, the market regards the plan as a step toward long-awaited fiscal co-ordination. The seeming breakthrough led to the euro strengthening, and importantly allowed the US dollar to weaken, taking the pressure off some of the more vulnerable economies within emerging markets. If this rotation is 'for real', and there have been failed attempts in the past, the equity exposure in the Company will perform handsomely. If this turns out to be another false start, we should continue to see benefits from the inflation-linked bonds and gold.

 

 

The last two months have provided credence to those that believe that central banks will forever be able to control the path of asset prices. We would argue differently: in the last three months governments have adopted a wartime response of huge, debt-funded fiscal spending, aided by central bank liquidity, and in the process are dismantling the anti-inflation bias constructed after the 1970s. To us this means we could quite quickly see the inflationary consequences of deep financial repression. Such a change will likely lead to a very different (and potentially more dangerous) market environment for investors.

 

 

 

 

 

Enquiries:

 

Praxis Fund Services Limited

Gail Adams

DDI: +44(0)1481 755584

Email: ric@praxisifm.com 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DOCEKLFBBQLZBBV
Date   Source Headline
1st May 20241:35 pmRNSNet Asset Value(s)
1st May 202411:36 amRNSTotal Voting Rights
24th Apr 20242:21 pmRNSNet Asset Value(s)
18th Apr 20247:00 amRNSTransaction in Own Shares
17th Apr 20242:19 pmRNSNet Asset Value(s)
17th Apr 20247:00 amRNSTransaction in Own Shares
16th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20242:09 pmRNSNet Asset Value(s)
10th Apr 202410:31 amRNSMonthly Investment Report - March 2024
10th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20244:33 pmRNSDirector/PDMR Shareholding
9th Apr 20247:07 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSTransaction in Own Shares
4th Apr 20247:00 amRNSTransaction in Own Shares
3rd Apr 20242:25 pmRNSNet Asset Value(s)
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20241:39 pmRNSNet Asset Value(s)
2nd Apr 202410:27 amRNSTotal Voting Rights
2nd Apr 20247:00 amRNSTransaction in Own Shares
28th Mar 20247:14 amRNSTransaction in Own Shares
27th Mar 20241:37 pmRNSNet Asset Value(s)
27th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 20247:00 amRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20247:00 amRNSTransaction in Own Shares
20th Mar 20242:58 pmRNSNet Asset Value(s)
18th Mar 20247:30 amRNSRuffer LLP Senior Management Share Purchase
18th Mar 20247:15 amRNSTransaction in Own Shares
18th Mar 20247:00 amRNSNet Asset Value(s) (replacement)
15th Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 202412:52 pmRNSNet Asset Value(s)
13th Mar 20247:30 amRNSBlock listing Interim Review
13th Mar 20247:00 amRNSTransaction in Own Shares
12th Mar 20247:00 amRNSMonthly Investment Report - February 2024
12th Mar 20247:00 amRNSTransaction in Own Shares
8th Mar 20247:00 amRNSTransaction in Own Shares
7th Mar 20247:00 amRNSKepler Trust Intelligence: New Research
7th Mar 20247:00 amRNSTransaction in Own Shares
6th Mar 202411:47 amRNSNet Asset Value(s)
1st Mar 202412:04 pmRNSNet Asset Value(s)
1st Mar 202410:34 amRNSTotal Voting Rights
1st Mar 20247:00 amRNSTransaction in Own Shares
29th Feb 20247:01 amRNSDividend Declaration
29th Feb 20247:00 amRNSHalf-year Report
28th Feb 202412:11 pmRNSNet Asset Value(s)
28th Feb 20247:00 amRNSTransaction in Own Shares
26th Feb 20247:00 amRNSTransaction in Own Shares
23rd Feb 20247:00 amRNSTransaction in Own Shares
22nd Feb 20248:09 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.